Advertisement
Advertisement
Capstone Therapeutics Corp. (CAPS)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 10:39AM EDT
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 37.00 |
| Open | 37.00 |
| Bid | 0.23 x 10000 |
| Ask | 0.29 x 10000 |
| Day's Range | 37.00 - 37.00 |
| 52 Week Range | 6.10 - 37.50 |
| Volume | |
| Avg. Volume | 32 |
| Market Cap | 2.933M |
| Beta (5Y Monthly) | 0.54 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -47.70 |
| Earnings Date | Aug 13, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- ACCESSWIRE
Capstone Holding Corp. Announces Exercise Of Secured Debt And Interest Conversion Option By Majority Shareholder, BP Peptides, LLC
ALSIP, IL / ACCESSWIRE / June 21, 2022/Capstone Holding Corp. (OTCQB:CAPS) ("the Company")EXERCISE OF SECURED DEBT AND INTEREST CONVERSION OPTION; ISSUANCE OF 78,333 SHARES OF THE COMPANY'S COMMON STOCKOn June 15, 2022, BP Peptides, LLC ("Brookstone") exercised its right to convert $1,938,746 of accrued interest and debt from its Senior Secured Note(s) into 78,333 shares of the Company's Common Stock (exercise price of $24.
- ACCESSWIRE
Capstone Therapeutics Corp. Announces Results of Annual Meeting
ALSIP, IL / ACCESSWIRE / December 2, 2021 / Capstone Therapeutics Corp. (OTCQB:CAPS) ("the Company"):The Annual Meeting of Stockholders of Capstone Therapeutics Corp.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
